U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06809075) titled 'Immunological Reset to Allow Acces to Kidney Trasplantation HLA Compatibe in Hyperimmunized Patients' on Oct. 03, 2024.
Brief Summary: This is a study for hypersensitized patients who have been waiting for more than 3 years for an offer for a kidney transplant. The objective is to perform a transplant of autologous hematopoietic precursors with the aim of producing what we call an immunological reset to make the maximum number of anti-HLA antibodies disappear and thus increase the chances of the patient receiving an offer for a kidney transplant.
Study Start Date: April 05, 2024
Study Type: INTERVENTIONAL
Condition:
Kidney Diseas...